Cargando…
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the pa...
Autores principales: | Skapenko, Alla, Schulze-Koops, Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748886/ https://www.ncbi.nlm.nih.gov/pubmed/36517627 http://dx.doi.org/10.1038/s41584-022-00892-3 |
Ejemplares similares
-
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021) -
Rheumatic disease and COVID-19: epidemiology and outcomes
por: Hyrich, Kimme L., et al.
Publicado: (2020) -
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
por: Schulze-Koops, Hendrik, et al.
Publicado: (2017) -
Reactive arthritis after SARS-CoV-2 infection
por: Dombret, Sophia, et al.
Publicado: (2022) -
Regulatory T cells in rheumatoid arthritis
por: Leipe, Jan, et al.
Publicado: (2005)